Thursday, 2 May, 2024
HomeVaccine Research

Vaccine Research

One HPV jab effective for three years, gold-standard Kenya trial finds

A single dose of the human papillomavirus vaccine is effective at preventing infections over three years, most likely lowering rates of cervical cancer and...

American Chemical Society overview of potential therapeutic agents and vaccines for COVID-19

Since the first reports of a new coronavirus disease in Wuhan, China, in December 2019, COVID-19 has spread rapidly across the globe, threatening a...

First analysis of potential targets for immune response — J Craig Venter and La Jolla institutes

A team of researchers at La Jolla Institute for Immunology, in collaboration with researchers at the J Craig Venter Institute, provides the first analysis...

Coronavirus infected monkeys that recovered developed effective immunity

Tests on monkeys suggest that patients who appear to have been "re-infected" may have been presenting symptoms from the same infection, reports The Daily...